STYK1

Chr 12

serine/threonine/tyrosine kinase 1

Also known as: NOK, SuRTK106

STYK1 encodes a receptor protein tyrosine kinase that regulates cell proliferation, differentiation, and survival through MAP kinase and PI3K signaling pathways. Mutations cause autosomal recessive developmental delay with variable intellectual disability and behavioral abnormalities. The gene shows very low constraint against loss-of-function variants, consistent with a recessive inheritance pattern.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
5
Pubs (1 yr)
39
P/LP submissions
0%
P/LP missense
1.19
LOEUF
Multiple*
Mechanism· predicted
Clinical SummarySTYK1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
39 unique Pathogenic / Likely Pathogenic· 62 VUS of 118 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.19LOEUF
pLI 0.000
Z-score 0.88
OE 0.80 (0.551.19)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.03Z-score
OE missense 0.99 (0.891.11)
236 obs / 237.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.80 (0.551.19)
00.351.4
Missense OE0.99 (0.891.11)
00.61.4
Synonymous OE0.90
01.21.6
LoF obs/exp: 18 / 22.5Missense obs/exp: 236 / 237.3Syn Z: 0.74
DN
0.7035th %ile
GOF
0.75top 25%
LOF
0.2580th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

118 submitted variants in ClinVar

Classification Summary

Pathogenic37
Likely Pathogenic2
VUS62
Likely Benign4
Benign2
37
Pathogenic
2
Likely Pathogenic
62
VUS
4
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
37
0
37
Likely Pathogenic
0
0
2
0
2
VUS
0
59
3
0
62
Likely Benign
0
3
0
1
4
Benign
0
1
0
1
2
Total063422107

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

STYK1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →